However, these drugs were never originally designed for long-term obesity control
PlexusDx Precision Peptide Genetic Test analyzes key variants in your GLP-1 receptor pathway, including GLP1R rs6923761, to reveal how your body is likely to respond to GLP-1 therapy
GLP-1 supplement gummies as finished products have not been clinically studied at the dosages and combinations used by commercial brands
The Monitoring Program includes substances which are not on the Prohibited List, but that WADA wishes to monitor in order to detect potential patterns of misuse in sport. A spokesperson for Novo Nordisk said in a statement that the pharmaceutical company, which produces and distributes GLP-1s, agreed with WADAs decision to monitor GLP-1 usage: We are supportive of the WADA recommendation, and we strongly discourage use/promotion outside the indicated population and approved label. Advertisement A spokesperson for Eli Lilly, another company that manufactures and distributes GLP-1s, said: Zepbound (tirzepatide) and Foundayo (orforglipron) are indicated for use, along with diet and exercise, for adults with obesity or overweight and a weight-related comorbidity
Eli Lilly's medicinal-chemistry effort optimised the peptide to a specific activity ratio that produces net metabolic benefit in studies which is why Retatrutide is described as a "balanced" triple agonist rather than simply a triple agonist
